Skip to Content
Merck
  • Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis.

Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis.

Ophthalmology (1997-05-01)
C J Helm, G N Holland, R G Webster, R K Maloney, B J Mondino
ABSTRACT

Pseudomonal scleritis is a serious and potentially blinding infection that usually is resistant to medical management. Results for three patients with pseudomonal scleritis who were treated with both topical anti-infectives and a combination of intravenous ceftazidime and aminoglycoside are presented in this case series. All three patients had a rapid response to the addition of combination intravenous drug therapy to topical therapy; eradication of the infection and healing of the ocular surface occurred within 8 weeks. Only one patient, in whom cystoid macular edema developed, lost useful vision as a result of the infection. Combination therapy with intravenous ceftazidime and aminoglycoside may be more effective than single-intravenous agents when used in addition to topical antibiotics and may obviate the need for adjunctive surgical procedures, such ascryotherapy, surgical extirpation, or conjunctival recession.

MATERIALS
Product Number
Brand
Product Description

Ceftazidime for peak identification, European Pharmacopoeia (EP) Reference Standard
USP
Ceftazidime pentahydrate, United States Pharmacopeia (USP) Reference Standard
Ceftazidime, European Pharmacopoeia (EP) Reference Standard